Three drugs, Ibuprofen, Aspirin and Erythromycin, are encapsulated in spherical Pluronic F127 micelles. The shapes and the size distributions of the micelles in dilute, aqueous solutions, with and without drugs, are ascertained using cryo-Scanning Electron Microscopy and Dynamic Light Scattering (DLS) experiments, respectively. Uptake of drugs above a threshold concentration is seen to reduce the critical micellization temperature of the solution. The mean hydrodynamic radii and polydispersities of the micelles are found to increase with decrease in temperature and in the presence of drug molecules. The hydration of the micellar core at lower temperatures is verified using fluorescence measurements. Increasing solution pH leads to the ionization of the drugs incorporated in the micellar cores. This causes rupture of the micelles and release of the drugs into the solution at the highest solution pH value of 11.36 investigated here and is studied using DLS and fluorescence spectrocopy.
INTRODUCTION
In recent times, block copolymers have emerged as a potential agent for targeted drug delivery and gene therapy [1] [2] [3] [4] [5] . One such block copolymer proposed for controlled drug delivery is Pluronic, which has a triblock PEO-PPO-PEO structure (PEO: polyethylene oxide, PPO: polypropylene oxide). At high temperatures, the central PPO block becomes hydrophobic, while the PEO blocks remain hydrophilic [6] . Due to this amphiphilic nature, Pluronic molecules, above a critical temperature and concentration, self-aggregate in aqueous solutions to form spherical micelles with hydrophobic PPO cores surrounded by hydrophilic PEO coronas. As the copolymer concentration is increased, the micelles can arrange themselves in cubic crystalline order [7, 8] . This results in a transition from a liquid to a soft solid phase [9] . The micellization process and the phase behavior of pure Pluronic solutions are found to depend upon solution temperature, copolymer concentration and molecular architecture and have been studied using differential scanning calorimetry (DSC), static and dynamic light scattering (SLS and DLS, respectively), small angle neutron scattering (SANS) and surface tension measurements [10] [11] [12] [13] .
The sizes of Pluronic micelles and the phase behavior of Pluronic solutions show dramatic changes in the presence of certain additives. The addition of the anionic surfactant sodium dodecyl sulphate (SDS) to micellar Pluronic solutions, for example, leads to the formation of mixed micelles. These solutions have been studied using DSC, isothermal titration calorimetry (ITC), SLS and DLS, electromotive force (emf) and surafce tension measurements and rheology [14] [15] [16] [17] [18] [19] [20] .
The formation of micellar block copolymer-drug complexes was first proposed by Dorn et al. [21] . When hydrophobic drug molecules are mixed with suitable quantities of Pluronic molecules and the temperature is raised, the drug molecules accumulate in the hydrophobic PPO cores. The hydrated PEO coronas are non-toxic and prevent the drug molecules from being removed from the core. The solubilities of the hydrophobic drugs therefore increase substantially in an aqueous medium, enhancing the bioavailability of the drugs [22] . It has been reported that the passive accumulation of drugs encapsulated in Pluronic micelles at solid tumor cells is more efficient than that of free drugs [2] . This arises from the long circulation time of the drug-encapsulated micelles and the slow dissociation of drugs from these micelles in the blood circulation system [2] . Drug-encapsulated Pluronic micelles can also 2 enhance the transport of drugs across the blood-brain and intestinal barriers [1, 2]. These and other pharmaceutical advantages of Pluronic micelles make it a serious contender as a drug carrier [23] .
The solubilization of drugs in Pluronic micelles has been extensively studied in recent times. It is reported in the literature that the presence of the hydrophobic drug molecules naproxen and indomethacin in F127 solutions results in slight decreases in the micellar sizes and aggregation numbers, in addition to a lowering of the gelation temperature [24] .
The aggregation behavior of F127 micelles was studied systematicaly when drugs of varying hydrophobicities were incorporated in the micellar cores [25] . It was found that the most hydrophobic drugs increased the sizes of the micellar core and corona while generally decreasing the micellar aggregation numbers. Scherlund et al. observed a decrease in the critical micellization temperature (CMT) and the gelation temperature when local anesthetics were added to Pluronic solutions [4] . These authors further confirmed that these temperatures decreased with dilution and increase in solution pH. More recently, Foster et al. encapsulated Ibuprofen molecules in Pluronic P-104 and P-105 solutions and Flurbiprofen molecules in P103 and P123 solutions. Using SANS and pulsed-field gradient stimulated-echo nuclear magnetic resonance (NMR) measurements, they demonstrated that the encapsulation of drugs favors the micellization process, resulting in an increase in the aggregation number and the micellar core radius [26, 27] . A strong dependence of the aggregation number and the core radius on the solution pH was reported when Ibuprofen was added to P104 solutions and Flurbiprofen to P103 and P123 solutions [28, 29] .
In this work, the non-steroidal anti-inflammatory drug Ibuprofen, the salicylate analgesic drug Aspirin and the macrolide antibiotic drug Erythromycin are encapsulated in the hydrophobic cores of spherical Pluronic F127 micelles. The dilute, completely fluid-like F127 solutions used here are studied at several temperatures and pH values and are prepared at concentrations that are much higher than the critical micellization concentrations of F127 at the temperatures studied. The encapsulation of drugs in Pluronic F127 micelles is studied using cryo-SEM, DLS, small angle X-ray scattering and fluorescence spectroscopy. The changes in the CMTs of the solutions, the variations in the hydrodynamic radii of the micelles containing the encapsulated drugs and the micellar polydispersities are investigated using DLS. The temperature dependence of the encapsulation process and the penetration of solvent in the micellar core are studied using fluorescence spectroscopy. Finally, the release 3 of the drugs from the micellar cores when solution pH is increased is reported. to measure the intensity auto-correlation functions of the light scattered from the samples.
The intensity auto-correlation function
, where I(τ ) is the intensity at time τ , g (1) (τ ) is the normalized electric field auto-correlation function, A is the coherence factor, and the angular brackets <> represent an average over time. If the sample is monodisperse and dilute, is the scattering wave vector at a scattering angle θ and for a wavelength λ. The effective hydrodynamic radius R H of the scatterer is estimated using the Stokes-Einstein relation
H , where k B is the Boltzmann constant, T is the temperature and η is the viscosity of the solvent [34] . Since the samples used in this study were highly polydisperse, The samples were then kept in quartz cells and excited with light of wavelength 339 nm in a Horiba Jobin Yvon FluoroMax-4 Spectrofluorometer. Changes in the emission spectra due to drug incorporation and changes in temperature and pH were detected using a R928P photomultiplier tube. This method is widely used to study micellization phenomena [35] [36] [37] [38] [39] [40] .
Small angle X-ray scattering (SAXS). Small angle X-ray scattering (SAXS)
was performed using a Hecus S3-Micro System using a Cu K α (λ = 1.54Å). The scattered intensity was measured with a one-dimensional position sensitive detector (PSD). The X-ray diffraction studies were carried out on samples loaded in 1.0 mm diameter glass capillaries.
2.6. pH measurement. pH measurements were done using an Eutech pH-meter. The pH-meter was calibrated by using three buffer solutions of pH 4.01, 7.00 and 10.01. with previous results obtained using DSC [10] , SLS and fluorescence spectroscopy [43] and is also confirmed by our cryo-SEM images which show that the F127 solution, quenched rapidly from 25
• C, is constituted by spherical micelles (Fig. 2(a) ).
DLS measurements were next performed after incorporating different quantities of drug molecules in 5.26 wt% F127 solutions in the temperature range 12
• C -60 • C. It was observed that the C(τ ) data in this entire temperature range fit well to stretched exponential functions (Fig. 4) . For all the data acquired, 1/ < τ R > varies linearly with q 2 (inset (a) of Table 1 , the octanol-water partition coefficients (log [P oct/water ]) [44] , which are measures of the hydrophobicity of the three drugs used here, are listed alongside our estimates of C t . It is seen that an increase in the partition coefficient reduces C t , thereby favoring the formation of micelles at lower concentrations.
SAXS measurements were also performed to confirm the lowering of the CMT of an Table S1 of Supporting Information).
In To confirm the increased hydration of the micellar core due to decrease in solution temperature, fluorescence spectra of the samples were recorded using aromatic pyrene molecules as the fluorescent probe. Pyrene molecules, being hydrophobic, stay encapsulated in the PPO cores of the micelles. The samples were excited at a wavelength of 339 nm with a bandwidth of 1 nm. The emission spectra, recorded at 40
• C and 8
• C, are shown in Fig. 6 (a) (solid line and circle-line, respectively). In both these spectra, the first peak, I 1 , occurs at around 372 nm and the third peak, I 3 , occurs at around 383 nm.
Earlier studies have shown that the intensity ratio between the first and third emission peaks of the pyrene spectrum (I 1 /I 3 ) depends upon the dipole moment of the solvent [39, 40, 45] . A significant enhancement in the intensity of the 0-0 vibronic band (which results in the I 1 peak) in the presence of a polar solvent has been reported. The I 3 peak, in contrast, is solvent-insensitive. A transition from a non-polar to a polar environment therefore results in a significant increase of the I 1 /I 3 ratio in the pyrene emission spectrum. In shows a very high value of around 1.7 at 8
• C which indicates that the pyrene molecules are in a fully aqueous environment [45] . The high values of I 1 /I 3 seen in our measurements for low drug encapsulation ( Fig. 6(b) ) indicate that the pyrene molecules are released into the aqueous environment at 8
• C due to the breakup of the micelles into unimers. For the other two samples with higher drug encapsulation, the increase in I 1 /I 3 at lower temperature is much less, which indicates a more limited amount of sovent penetration in the micellar cores. Inset of Fig. 7(b) shows that as solution pH is changed between 4.65 and 11.36, 1/ < τ R >, extracted from DLS data acquired 40
• C, shows a power law dependence on q:
Here, the exponent α gives information about the micellar dynamics. Table   S1 ). Furthermore, by observing changes in the shapes of C(τ ) from stretched exponential to non-exponential as temperature is decreased, the CMT of the sample at pH = 11.36 is estimated to be 24
• C, the value expected for pure F127 micellar solutions. This observation is similar to the findings of Scherlund et al., who observed that if the active ingredients (drugs) are mostly in ionized form at a certain pH, the CMT of the F127 solution is almost the same as that for the pure sample [4] . The release of drugs at high pH was previously also reported for Flurbiprofen-encapsulated P103 solutions [29] .
CONCLUSION
In this work, three different drugs, Ibuprofen, Aspirin and Erythromycin, are encapsulated in aqueous F127 micellar solutions. Cryo-SEM imaging shows the presence of globular structures even after drug-encapsulation. The drug molecules, when added above a specific threshold concentration C t , enhance the stability of the micellar phase over a broad temperature range. DLS experiments are performed on the drug-encapsulated micellar systems to determine changes in hydrodynamic radii and micellar polydispersities. The average hydrodynamic radii of the micelles calculated here are seen to increase upon drug incorporation, with the polydispersity being inversely correlated to the drug hydrophobicity at the higher temperatures. The hydrodynamic radii of the micelles increase with decrease in temperature. This is consistent with data presented in [24, 25] . The increase in micellar sizes observed when temperature is lowered is accompanied by an increase in the hydration of the micellar core and is verified by pyrene fluorescence spectra measurements. Increasing the temperature excludes the solvent from the micellar core due to enhanced core hydrophobicity and results in more compact micelles. The drug-encapsulated micelles also show a strong pH dependence. When pH increases from 4.65 to 6.1, the ionization of drug molecules leads to the formation of larger micelles. Increasing the pH to 11.36 triggers the release of drug molecules in the solvent. Drug-incorporated F127 micelles therfore have enormous potential as drug carriers in the area of nanomedicine [23] . However, before these formulations are made available commercially, several clinical and scientific issues relating to their toxicity and stability need to be addressed. [2] Kwon, G. S.; Kataoka, K. Block copolymer micelles as long-circulating drug vehicles. Adv.
Drug Del. Reviews 1995, 16, 295. 
